Potential Mechanobiological Consequences of Injectable Aesthetic Procedures: Dermal Fillers, Botulinum Toxin, ECM Dynamics, Lymphovascular Drainage, and the Concept of Mechanical Silence
- 1V Plastic Surgery, Daegu 41940, Republic of Korea;
- 2Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, , Seoul 03722, Republic of Korea
- 3Aesthefora Inc., Seoul 04364, Republic of Korea
Abstract
Injectable aesthetic procedures are commonly discussed in terms of volumization, muscle relaxation, wrinkle reduction, and adverse events, whereas their potential effects on the dynamic mechanical environment of facial soft tissues have received less attention. The dermis is a mechanosensitive, viscoelastic tissue in which fibroblasts, extracellular matrix (ECM), interstitial fluid, vascular and lymphatic physiology, and repeated facial motion interact. Established evidence demonstrates that appropriately used hyaluronic acid fillers can restore structural support and stimulate collagen remodeling, while botulinum toxin reduces muscle contraction and dynamic rhytides. By contrast, direct clinical evidence that injectable procedures produce sustained abnormalities in tissue mechanics, lymphatic pumping, or mechanotransductive signaling remains limited. This narrative review integrates established clinical evidence, mechanistic evidence from adjacent fields, and hypothesis-generating interpretations to propose the concept of injectable procedure-related “mechanical silence”: a localized reduction or distortion of physiological tissue deformation, fluid exchange, and cell–matrix mechanical signaling. The concept is not presented as a demonstrated adverse effect or as evidence that fillers or botulinum toxin accelerate aging. Rather, it provides a testable framework for investigating whether selected patterns of excessive volume, altered local stiffness, persistent edema, or marked reduction in muscle-driven tissue motion are associated with measurable changes in tissue biomechanics. Pressure-injury biology is discussed only as a conceptual example of the consequences of sustained deformation and impaired tissue mobility and is not considered mechanically or clinically equivalent to aesthetic injectable treatment. Future studies should combine structural imaging with quantitative assessment of tissue stiffness, deformation and recoil, filler burden, lymphatic transit, perfusion, muscle excursion, and mechanotransductive biomarkers to determine whether the proposed framework has clinical relevance.
Related
- Association of Implantation Depth With Hemodynamics and Mechanical Consequences in Small Valve-In-Valve TAVR.
- 396 Slit2–Robo1/2 signaling orchestrates a lymphovascular–myeloid axis that limits T cell priming and drives immunotherapy resistance
- Association of HER2, p53, and lymphovascular space invasion with lymph node metastasis in endometrial cancer: a retrospective cohort study
- Limited-site adaptation reveals representation-specific MRI transportability for lymphovascular invasion in endometrial cancer
- Explosive cervical lymph node recurrence following two-field lymphadenectomy in pT1b (SM2) middle esophageal squamous cell carcinoma with INFb pattern and absent lymphovascular invasion: a case report
BibTeX
@article{choi2026potential,
title = {{Potential Mechanobiological Consequences of Injectable Aesthetic Procedures: Dermal Fillers, Botulinum Toxin, ECM Dynamics, Lymphovascular Drainage, and the Concept of Mechanical Silence}},
author = {Wonseok Choi and Kyu-Ho Yi and Olena Sydorchuk},
journal = {Bioengineering (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/bioengineering13101219},
url = {https://europepmc.org/article/PMC/PMC13701878},
note = {CC BY},
}
RIS
TY - JOUR
TI - Potential Mechanobiological Consequences of Injectable Aesthetic Procedures: Dermal Fillers, Botulinum Toxin, ECM Dynamics, Lymphovascular Drainage, and the Concept of Mechanical Silence
AU - Wonseok Choi
AU - Kyu-Ho Yi
AU - Olena Sydorchuk
PY - 2026
DA - 2026/10/01
JO - Bioengineering (Basel, Switzerland)
DO - 10.3390/bioengineering13101219
UR - https://europepmc.org/article/PMC/PMC13701878
AB - Injectable aesthetic procedures are commonly discussed in terms of volumization, muscle relaxation, wrinkle reduction, and adverse events, whereas their potential effects on the dynamic mechanical environment of facial soft tissues have received less attention. The dermis is a mechanosensitive, viscoelastic tissue in which fibroblasts, extracellular matrix (ECM), interstitial fluid, vascular and lymphatic physiology, and repeated facial motion interact. Established evidence demonstrates that appropriately used hyaluronic acid fillers can restore structural support and stimulate collagen remodeling, while botulinum toxin reduces muscle contraction and dynamic rhytides. By contrast, direct clinical evidence that injectable procedures produce sustained abnormalities in tissue mechanics, lymphatic pumping, or mechanotransductive signaling remains limited. This narrative review integrates established clinical evidence, mechanistic evidence from adjacent fields, and hypothesis-generating interpretations to propose the concept of injectable procedure-related “mechanical silence”: a localized reduction or distortion of physiological tissue deformation, fluid exchange, and cell–matrix mechanical signaling. The concept is not presented as a demonstrated adverse effect or as evidence that fillers or botulinum toxin accelerate aging. Rather, it provides a testable framework for investigating whether selected patterns of excessive volume, altered local stiffness, persistent edema, or marked reduction in muscle-driven tissue motion are associated with measurable changes in tissue biomechanics. Pressure-injury biology is discussed only as a conceptual example of the consequences of sustained deformation and impaired tissue mobility and is not considered mechanically or clinically equivalent to aesthetic injectable treatment. Future studies should combine structural imaging with quantitative assessment of tissue stiffness, deformation and recoil, filler burden, lymphatic transit, perfusion, muscle excursion, and mechanotransductive biomarkers to determine whether the proposed framework has clinical relevance.
SN - 2306-5354
ER -